Assessing Clinical Trial Experiences of Patients With Osteosarcoma
Not yet recruiting
- Conditions
- Osteosarcoma
- Registration Number
- NCT05535283
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical study participation has historically been heavily biased toward specific demographics.
Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient has been diagnosed with osteosarcoma
- Patient has self-identified as planning to enroll in an interventional clinical trial
- Patient is a minimum of 18 years or older
Exclusion Criteria
- ECOG score of 4
- Patient is pregnant
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who remain in osteosarcoma clinical trial to trial completion 12 months Number of patients who decide to enroll in an osteosarcoma clinical trial 3 months
- Secondary Outcome Measures
Name Time Method